Applications of Metabolomics for Kidney Disease Research

References

• Siew ED, Ware LB, Ikizler TA. Biological markers of acute kidney injury. J Am Soc Nephrol 2011; 22:810 - 20; http://dx.doi.org/10.1681/ASN.2010080796; PMID: 21493774
   PubMed Web of Science ®Google Scholar
• Kind T, Tolstikov V, Fiehn O, Weiss RH. A comprehensive urinary metabolomic approach for identifying kidney cancerr. Anal Biochem 2007; 363:185 - 95; http://dx.doi.org/10.1016/j.ab.2007.01.028; PMID: 17316536
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Lindon JC. Systems biology: Metabonomics. Nature 2008; 455:1054 - 6; http://dx.doi.org/10.1038/4551054a; PMID: 18948945
   PubMed Web of Science ®Google Scholar
• Jellum E, Stokke O, Eldjarn L. Application of gas chromatography, mass spectrometry, and computer methods in clinical biochemistry. Anal Chem 1973; 46:1099 - 106; PMID: 4201587
   PubMedGoogle Scholar
• Shoemaker JD, Elliott WH. Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr 1991; 562:125 - 38; http://dx.doi.org/10.1016/0378-4347(91)80571-S; PMID: 2026685
   PubMed Web of Science ®Google Scholar
• Kuhara T, Shinka T, Inoue Y, Ohse M, Zhen-wei X, Yoshida I, et al. Pilot study of gas chromatographic-mass spectrometric screening of newborn urine for inborn errors of metabolism after treatment with urease. J Chromatogr B Biomed Sci Appl 1999; 731:141 - 7; http://dx.doi.org/10.1016/S0378-4347(99)00205-4; PMID: 10492000
   PubMed Web of Science ®Google Scholar
• Kuhara T. Gas chromatographic-mass spectrometric urinary metabolome analysis to study mutations of inborn errors of metabolism. Mass Spectrom Rev 2005; 24:814 - 27; http://dx.doi.org/10.1002/mas.20038; PMID: 15376278
   PubMed Web of Science ®Google Scholar
• Gika HG, Theodoridis GA, Wingate JE, Wilson ID. Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. J Proteome Res 2007; 6:3291 - 303; http://dx.doi.org/10.1021/pr070183p; PMID: 17625818
   PubMed Web of Science ®Google Scholar
• Reo NV. NMR-based metabolomics. Drug Chem Toxicol 2002; 25:375 - 82; http://dx.doi.org/10.1081/DCT-120014789; PMID: 12378948
   PubMed Web of Science ®Google Scholar
• Veenstra TD. Metabolomics: the final frontier?. Genome Med 2012; 4:40; http://dx.doi.org/10.1186/gm339; PMID: 22546050
   PubMedGoogle Scholar
• Weiss RH, Kim K. Metabolomics in the study of kidney diseases. Nat Rev Nephrol 2012; 8:22 - 33; http://dx.doi.org/10.1038/nrneph.2011.152; PMID: 22025087
   PubMed Web of Science ®Google Scholar
• Griffiths WJ, Koal T, Wang Y, Kohl M, Enot DP, Deigner HP. Targeted metabolomics for biomarker discovery. Angew Chem Int Ed Engl 2010; 49:5426 - 45; http://dx.doi.org/10.1002/anie.200905579; PMID: 20629054
   PubMed Web of Science ®Google Scholar
• Vivó-Truyols G, Torres-Lapasió JR, van Nederkassel AM, Vander Heyden Y, Massart DL. Automatic program for peak detection and deconvolution of multi-overlapped chromatographic signals part I: peak detection. J Chromatogr A 2005; 1096:133 - 45; http://dx.doi.org/10.1016/j.chroma.2005.03.092; PMID: 16301076
   PubMed Web of Science ®Google Scholar
• Taylor SL, Ganti S, Bukanov NO, Chapman A, Fiehn O, Osier M, et al. A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease. Am J Physiol Renal Physiol 2010; 298:F909 - 22; http://dx.doi.org/10.1152/ajprenal.00722.2009; PMID: 20130118
   PubMedGoogle Scholar
• Belldegrun AS, Klatte T, Shuch B, LaRochelle JC, Miller DC, Said JW, et al. Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies. Cancer 2008; 113:2457 - 63; http://dx.doi.org/10.1002/cncr.23851; PMID: 18823034
   PubMed Web of Science ®Google Scholar
• Kim K, Taylor SL, Ganti S, Guo L, Osier MV, Weiss RH. Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer. OMICS 2011; 15:293 - 303; http://dx.doi.org/10.1089/omi.2010.0094; PMID: 21348635
   PubMed Web of Science ®Google Scholar
• Ganti S, Taylor SL, Abu Aboud O, Yang J, Evans C, Osier MV, et al. Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis. Cancer Res 2012; 72:3471 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-11-3105; PMID: 22628425
   PubMed Web of Science ®Google Scholar
• Ganti S, Taylor SL, Kim K, Hoppel CL, Guo L, Yang J, et al. Urinary acylcarnitines are altered in human kidney cancer. Int J Cancer 2012; 130:2791 - 800; http://dx.doi.org/10.1002/ijc.26274; PMID: 21732340
   PubMed Web of Science ®Google Scholar
• Melnick JZ, Baum M, Thompson JR. Aminoglycoside-induced Fanconi’s syndrome. Am J Kidney Dis 1994; 23:118 - 22; PMID: 8285185
   PubMed Web of Science ®Google Scholar
• Boudonck KJ, Mitchell MW, Német L, Keresztes L, Nyska A, Shinar D, et al. Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol Pathol 2009; 37:280 - 92; http://dx.doi.org/10.1177/0192623309332992; PMID: 19380839
   PubMed Web of Science ®Google Scholar
• Xu EY, Perlina A, Vu H, Troth SP, Brennan RJ, Aslamkhan AG, et al. Integrated pathway analysis of rat urine metabolic profiles and kidney transcriptomic profiles to elucidate the systems toxicology of model nephrotoxicants. Chem Res Toxicol 2008; 21:1548 - 61; http://dx.doi.org/10.1021/tx800061w; PMID: 18656965
   PubMed Web of Science ®Google Scholar
• Suhre K, Meisinger C, Doring A, Altmaier E, Belcredi P, Gieger C, et al. Hrabe de, Angelis M., Wichmann, H. E., Kronenberg, F., Adamski, J., and Illig, T.,Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE 2010; 5:e13953; http://dx.doi.org/10.1371/journal.pone.0013953
   PubMed Web of Science ®Google Scholar
• Zhao X, Fritsche J, Wang J, Chen J, Rittig K, Schmitt-Kopplin P, et al. Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics 2010; 6:362 - 74; http://dx.doi.org/10.1007/s11306-010-0203-1; PMID: 20676218
   PubMed Web of Science ®Google Scholar
• Connor SC, Hansen MK, Corner A, Smith RF, Ryan TE. Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. Mol Biosyst 2010; 6:909 - 21; http://dx.doi.org/10.1039/b914182k; PMID: 20567778
   PubMed Web of Science ®Google Scholar
• Mahadevan S, Shah SL, Marrie TJ, Slupsky CM. Analysis of metabolomic data using support vector machines. Anal Chem 2008; 80:7562 - 70; http://dx.doi.org/10.1021/ac800954c; PMID: 18767870
   PubMed Web of Science ®Google Scholar
• Kikuchi K, Itoh Y, Tateoka R, Ezawa A, Murakami K, Niwa T. Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878:1662 - 8; http://dx.doi.org/10.1016/j.jchromb.2009.11.040; PMID: 20036201
   PubMed Web of Science ®Google Scholar
• Toyohara T, Akiyama Y, Suzuki T, Takeuchi Y, Mishima E, Tanemoto M, et al. Metabolomic profiling of uremic solutes in CKD patients. Hypertens Res 2010; 33:944 - 52; http://dx.doi.org/10.1038/hr.2010.113; PMID: 20613759
   PubMed Web of Science ®Google Scholar
• Romick-Rosendale LE, Brunner HI, Bennett MR, Mina R, Nelson S, Petri M, et al. Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis. Arthritis Res Ther 2011; 13:R199; http://dx.doi.org/10.1186/ar3530; PMID: 22152586
   PubMedGoogle Scholar
• Sui W, Li L, Che W, Guimai Z, Chen J, Li W, et al. A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy. Clinics (Sao Paulo) 2012; 67:363 - 73; http://dx.doi.org/10.6061/clinics/2012(04)10; PMID: 22522762
   PubMed Web of Science ®Google Scholar
• Catchpole G, Platzer A, Weikert C, Kempkensteffen C, Johannsen M, Krause H, et al. Metabolic profiling reveals key metabolic features of renal cell carcinoma. J Cell Mol Med 2011; 15:109 - 18; http://dx.doi.org/10.1111/j.1582-4934.2009.00939.x; PMID: 19845817
   PubMed Web of Science ®Google Scholar
• Grantham JJ. Polycystic kidney disease: neoplasia in disguise. Am J Kidney Dis 1990; 15:110 - 6; PMID: 2405652
   PubMed Web of Science ®Google Scholar